Ex vivo modeling of HIV persistence in successfully treated subjects ...
Ex vivo modeling of HIV persistence in successfully treated subjects ...
Ex vivo modeling of HIV persistence in successfully treated subjects ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HPDA: Identify<strong>in</strong>g reactivation strategies<br />
Reactivation<br />
(% relative to CD3/CD28)<br />
15<br />
10<br />
5<br />
0<br />
Subject A<br />
10.0<br />
7.5<br />
5.0<br />
2.5<br />
0.0<br />
Subject B<br />
100<br />
75<br />
50<br />
25<br />
0<br />
Subject C<br />
The response <strong>of</strong> latently <strong>in</strong>fected cells to anti-latency agents is highly<br />
variable between virally suppressed <strong>subjects</strong>.
Change language